Literature DB >> 32970452

The Right Kind of Pooled Testing for the Novel Coronavirus: First, Do No Harm.

Eugene Litvak1, Susan Dentzer1, Marcello Pagano1.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32970452      PMCID： PMC7661983          DOI： 10.2105/AJPH.2020.305945

Source DB:  PubMed          Journal:  Am J Public Health        ISSN： 0090-0036            Impact factor:   9.308


× No keyword cloud information.
  2 in total

1.  Accurate Statistics on COVID-19 Are Essential for Policy Guidance and Decisions.

Authors:  Neil Pearce; Jan P Vandenbroucke; Tyler J VanderWeele; Sander Greenland
Journal:  Am J Public Health       Date:  2020-04-23       Impact factor: 9.308

2.  Evaluation of COVID-19 RT-qPCR Test in Multi sample Pools.

Authors:  Idan Yelin; Noga Aharony; Einat Shaer Tamar; Amir Argoetti; Esther Messer; Dina Berenbaum; Einat Shafran; Areen Kuzli; Nagham Gandali; Omer Shkedi; Tamar Hashimshony; Yael Mandel-Gutfreund; Michael Halberthal; Yuval Geffen; Moran Szwarcwort-Cohen; Roy Kishony
Journal:  Clin Infect Dis       Date:  2020-11-19       Impact factor: 9.079
  2 in total
  4 in total

1.  Natural language processing enabling COVID-19 predictive analytics to support data-driven patient advising and pooled testing.

Authors:  Stéphane M Meystre; Paul M Heider; Youngjun Kim; Matthew Davis; Jihad Obeid; James Madory; Alexander V Alekseyenko
Journal:  J Am Med Inform Assoc       Date:  2021-12-28       Impact factor: 7.942

Review 2.  Strategies for Scaling up SARS-CoV-2 Molecular Testing Capacity.

Authors:  Sanchita Das; Karen M Frank
Journal:  Clin Lab Med       Date:  2022-03-08       Impact factor: 2.172

3.  Is group testing ready for prime-time in disease identification?

Authors:  Gregory Haber; Yaakov Malinovsky; Paul S Albert
Journal:  Stat Med       Date:  2021-04-28       Impact factor: 2.497

4.  Identifying optimal COVID-19 testing strategies for schools and businesses: Balancing testing frequency, individual test technology, and cost.

Authors:  Gregory D Lyng; Natalie E Sheils; Caleb J Kennedy; Daniel O Griffin; Ethan M Berke
Journal:  PLoS One       Date:  2021-03-25       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.